An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (19)
  • Podcast (13)
  • (-) Publications (652)
  • Training (6)
  • User case (13)
  • User meeting (21)
  • Webinar (119)
  • White paper (8)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (79)
  • Breast (53)
  • Gastro-intestinal (117)
  • Genito-urinary (49)
  • Gynecological (7)
  • Head and neck (121)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (10)
  • Pediatric (89)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (84)
  • Reset filters
  • (-) Publications

Proton therapy reduces the effective dose to immune cells in breast cancer patients.

29/10/2024
/ Publications

The effective dose to circulating immune cells (EDIC) is associated with survival. This study from Institut Curie compared VMAT and IMPT in EDIC in patients...

Recent update of proton beam therapy for hepatocellular carcinoma: A systematic review and meta-analysis.

29/10/2024
/ Publications

This meta-analysis included 22 original studies involving 1858 HCC patients who received PBT to a total dose ranged from 55 GyE to 76 GyE. The median proportion...

Proton beam therapy and dentofacial development in paediatric cancer patients: A scoping review.

29/10/2024
/ Publications

This review focused on the impact of PBT on dentofacial development in pediatric patients treated for cancer in the head and neck region. This review included...

Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy.

29/10/2024
/ Publications

Published in the Green Journal, this survey study sent to 19 European PT centers revealed wide variations in planning approach and consequently dose to organs...

Particle arc therapy: Status and potential.

29/10/2024
/ Publications
/
ARC therapy

This comprehensive review provides perspectives from the European Society for Radiotherapy and Oncology (ESTRO) 2022 physics workshop on particle arc therapy...

Secondary cancer risk in six anatomical sites when using PAT, IMPT, and VMAT/IMRT radiotherapy.

29/10/2024
/ Publications
/
ARC therapy

With dosimetric data from 90 treatment plans of six anatomical sites, five patients per site and radiation delivered by IMPT, proton arc therapy (PAT) and VMAT...

Initial experience and patient tolerance of proton stereotactic body radiotherapy.

29/10/2024
/ Publications
/
Hypofractionation

This study reported treatment outcomes of 52 patients (62 lesions) treated with proton SBRT. Fractionation varied by indication and site with a median of 5...

Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy.

29/10/2024
/ Publications
/
Hypofractionation
Motion Management

This study from China investigated dose uncertainties induced by cardiorespiratory motion in proton therapy for arrhythmia. Twelve patients with refractory...

Comparison of clinical outcome between surgical treatment and particle beam therapy for pelvic bone sarcomas: A retrospective multicenter study in Japan.

29/10/2024
/ Publications

This study from Japan reported outcomes of 116 patients with pelvic bone sarcoma treated by surgery (n=57) and particle beam (n=59, 55 carbon ion, 4 proton)...

Impact of proton versus photon adjuvant radiotherapy on overall survival in the management of skull base and spinal chordomas: a National Cancer Database analysis.

29/10/2024
/ Publications

This study reported treatment outcomes of proton or photon adjuvant therapy for chordomas of the skull base and spine. Data of 424 patients from the National...

Pagination

  • Previous page ‹
    • Page 1
    • Current page 2
    • Page 3
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies